Prevalence of extended-spectrum β-lactamases in group-1 β-lactamase-producing isolates
- 1 May 2001
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 7 (5) , 278-282
- https://doi.org/10.1046/j.1198-743x.2001.00255.x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Detection of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacter cloacae and Enterobacter aerogenesJournal of Clinical Microbiology, 2000
- Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteria in MexicoMicrobial Drug Resistance, 1999
- Cefotaxime-Resistant Enterobacteriaceae Isolates from a Hospital in Warsaw, Poland: Identification of a New CTX-M-3 Cefotaxime-Hydrolyzing β-Lactamase That Is Closely Related to the CTX-M-1/MEN-1 EnzymeAntimicrobial Agents and Chemotherapy, 1998
- Plasmid-Mediated Resistance to Expanded-Spectrum Cephalosporins among Enterobacter aerogenes StrainsAntimicrobial Agents and Chemotherapy, 1998
- Is it important to identify extended-spectrum beta-lactamase-producing isolates?European Journal of Clinical Microbiology & Infectious Diseases, 1996
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995
- Dissemination of cephalosporin-resistantSerratia marcescens strains producing a plasmidic SHV type beta-lactamase in Greek hospitalsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- More extended-spectrum beta-lactamasesAntimicrobial Agents and Chemotherapy, 1991
- Rapid isoelectric focusing of plasmid-mediated beta-lactamases with Pharmacia PhastSystemAntimicrobial Agents and Chemotherapy, 1988
- Extended Broad-Spectrum -Lactamases Conferring Transferable Resistance to Newer -Lactam Agents in Enterobacteriaceae: Hospital Prevalence and Susceptibility PatternsClinical Infectious Diseases, 1988